Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 14.58 6.81% 0.93
FLXN closed up 6.81 percent on Friday, January 18, 2019, on 1.11 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical FLXN trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 50 DMA Bullish 0.00%
Jan 18 Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Jan 18 Above Upper BB Strength 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 Weak + Overbought Other 6.81%
Jan 17 Overbought Stochastic Strength 6.81%
Jan 16 50 DMA Resistance Bearish 8.81%
Jan 16 Stochastic Sell Signal Bearish 8.81%
Jan 16 Weak + Overbought Other 8.81%

Older signals for FLXN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Is FLXN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.1
52 Week Low 10.98
Average Volume 733,437
200-Day Moving Average 20.9881
50-Day Moving Average 14.3038
20-Day Moving Average 12.7685
10-Day Moving Average 13.498
Average True Range 0.8899
ADX 21.78
+DI 26.0285
-DI 20.9223
Chandelier Exit (Long, 3 ATRs ) 12.0603
Chandelier Exit (Short, 3 ATRs ) 13.6497
Upper Bollinger Band 14.5245
Lower Bollinger Band 11.0125
Percent B (%b) 1.02
BandWidth 27.505189
MACD Line -0.0432
MACD Signal Line -0.3402
MACD Histogram 0.2969
Fundamentals Value
Market Cap 465.18 Million
Num Shares 31.9 Million
EPS -3.11
Price-to-Earnings (P/E) Ratio -4.69
Price-to-Sales 0.00
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.56
Resistance 3 (R3) 16.39 15.56 16.23
Resistance 2 (R2) 15.56 15.06 15.65 16.12
Resistance 1 (R1) 15.07 14.74 15.32 15.24 16.01
Pivot Point 14.24 14.24 14.36 14.33 14.24
Support 1 (S1) 13.75 13.74 14.00 13.92 13.15
Support 2 (S2) 12.92 13.42 13.01 13.04
Support 3 (S3) 12.43 12.92 12.93
Support 4 (S4) 12.60